RxDoctor Payments Data

Karen Burnett, MD

Family Medicine · Westminster, CONPI 1639254386

Payments from drug & device makers

$6,003in general payments, 2019–2025

Across 333 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$430
  • AstraZeneca$396
  • Amgen$384
  • Lilly USA, LLC$340
  • Bayer$302
  • plus $3K from 40 others

What the payments were for

  • Consulting fees$230%
  • Food & beverage$5,94199%
  • Education$120%
  • Other$270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,003 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$78,728
Medicare patients
183
Services billed
1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf)Adalimumab14$112,811
OzempicSemaglutide58$82,305
EliquisApixaban24$36,359
JardianceEmpagliflozin18$34,797
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$32,457
XareltoRivaroxaban21$31,564
MounjaroTirzepatide24$28,907
LinzessLinaclotide25$20,237
Spiriva RespimatTiotropium Bromide14$19,169
MyrbetriqMirabegron11$15,315
SymbicortBudesonide/Formoterol Fumarate14$5,828
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$5,356
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,948
Levothyroxine Sodium223$3,564
Gabapentin116$3,456

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf), Linzess, Synthroid$1,298$135,68965 claims
Novo NordiskOzempic$222$82,30558 claims
Boehringer IngelheimJardiance, Spiriva Respimat$190$53,96632 claims
PfizerEliquis$430$36,35924 claims
GSKTrelegy Ellipta$280$32,45719 claims
Johnson & JohnsonXarelto$183$31,56421 claims
Lilly USA, LLCMounjaro$340$28,90724 claims
Astellas Pharma US IncMyrbetriq$134$15,31511 claims
AstraZenecaSymbicort$396$5,82814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Westminster

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →